Aaron Tabensky

Aaron Tabensky has a diverse work experience in the pharmaceutical and clinical research industry. Aaron currently works as a Project Director at Novotech since February 2021. Prior to that, they were an independent consultant at Aaron David Consulting from November 2020. Aaron also served as the Director of Clinical Operations & Medical Affairs at PROTA THERAPEUTICS PTY LTD from October 2018 to February 2021, and as the Director of Clinical Trial Management at Abbott from June 2016 to October 2018. Before that, they worked at Takeda as an Associate Director and Global Clinical Program Manager from February 2012 to May 2016. Additionally, they have experience as a Senior Clinical Project Manager at QuintilesIMS from April 2011 to February 2012, a Clinical Project Manager from September 2007 to March 2011, and a Senior Clinical Project Coordinator at Biogen from 2004 to 2007. Aaron also worked as a Clinical Research Associate II at PRA Health Sciences from 2002 to 2004 and as a Clinical Research Associate at Servier from 2000 to 2002.

Aaron Tabensky earned a PhD in Osteoporosis/Bone & Mineral Metabolism; Clinical Research from the University of Melbourne, where they studied from 1994 to 2000.